Cargando…

Changes in clinical and imaging variables during withdrawal of heart failure therapy in recovered dilated cardiomyopathy

AIMS: This study aimed to profile the changes in non‐invasive clinical, biochemical, and imaging markers during withdrawal of therapy in patients with recovered dilated cardiomyopathy, providing insights into the pathophysiology of relapse. METHODS AND RESULTS: Clinical, biochemical, and imaging dat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Halliday, Brian P., Owen, Ruth, Gregson, John, Vazir, Ali, Wassall, Rebecca, Khalique, Zohya, Lota, Amrit S., Tayal, Upasana, Hammersley, Daniel J., Jones, Richard E., Pennell, Dudley J., Cowie, Martin R., Cleland, John G.F., Prasad, Sanjay K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065828/ https://www.ncbi.nlm.nih.gov/pubmed/35257498 http://dx.doi.org/10.1002/ehf2.13872

Ejemplares similares

Heart Rate as a Marker of Relapse During Withdrawal of Therapy in Recovered Dilated Cardiomyopathy
por: Halliday, Brian P., et al.
Publicado: (2021)

Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial
por: Halliday, Brian P, et al.
Publicado: (2019)

Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic Dysfunction
por: Halliday, Brian P., et al.
Publicado: (2017)

Outcome in Dilated Cardiomyopathy Related to the Extent, Location, and Pattern of Late Gadolinium Enhancement
por: Halliday, Brian P., et al.
Publicado: (2019)

Sex‐ and age‐based differences in the natural history and outcome of dilated cardiomyopathy
por: Halliday, Brian P., et al.
Publicado: (2018)

The addition of genetic testing and cardiovascular magnetic resonance to routine clinical data for stratification of etiology in dilated cardiomyopathy
por: Amin, Ravi J., et al.
Publicado: (2022)

Moderate excess alcohol consumption and adverse cardiac remodelling in dilated cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2022)

Exposure to Elevated Nitrogen Dioxide Concentrations and Cardiac Remodeling in Patients With Dilated Cardiomyopathy
por: Fecht, DANIELA, et al.
Publicado: (2022)

Evaluation of CMR predictors of right ventricular remodelling in dilated cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2016)

Precision Phenotyping of Dilated Cardiomyopathy Using Multidimensional Data
por: Tayal, Upasana, et al.
Publicado: (2022)

Evaluating the significance of left ventricular midwall fibrosis detected by late gadolinium enhancement imaging on left ventricular functional remodelling in dilated cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2016)

Maintaining Success for Patients With Dilated Cardiomyopathy and Remission of Heart Failure
por: Halliday, Brian P., et al.
Publicado: (2022)

Myocardial remodelling and recovery in dilated cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2017)

Genetic Architecture of Acute Myocarditis and the Overlap With Inherited Cardiomyopathy
por: Lota, Amrit S., et al.
Publicado: (2022)

Prognostic Significance of Nonischemic Myocardial Fibrosis in Patients With Normal LV Volumes and Ejection-Fraction
por: Lota, Amrit S., et al.
Publicado: (2021)

Direct and indirect effect of the COVID-19 pandemic on patients with cardiomyopathy
por: Hammersley, Daniel J, et al.
Publicado: (2022)

Fibrosis entropy is associated with life-threatening arrhythmia in non-ischaemic cardiomyopathy
por: Zaidi, H, et al.
Publicado: (2023)

Genetics and genomics of dilated cardiomyopathy and systolic heart failure
por: Tayal, Upasana, et al.
Publicado: (2017)

Prognostic significance of midwall fibrosis in dilated cardiomyopathy
por: Gulati, Ankur, et al.
Publicado: (2012)

Advanced 3D analysis of fibrotic ring-like pattern in non-ischemic cardiomyopathy predicts major arrhythmic events
por: Zaidi, H, et al.
Publicado: (2023)

Diffusion tensor cardiovascular magnetic resonance in hypertrophic cardiomyopathy: a comparison of motion-compensated spin echo and stimulated echo techniques
por: Khalique, Zohya, et al.
Publicado: (2019)

Phenotype and Clinical Outcomes of Titin Cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2017)

The feasibility of a novel limited field of view spiral cine DENSE sequence to assess myocardial strain in dilated cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2019)

Sudden Cardiac Death Prediction in Non-ischemic Dilated Cardiomyopathy: a Multiparametric and Dynamic Approach
por: Hammersley, Daniel J., et al.
Publicado: (2020)

Late-Gadolinium Enhancement Interface Area and Electrophysiological Simulations Predict Arrhythmic Events in Patients With Nonischemic Dilated Cardiomyopathy
por: Balaban, Gabriel, et al.
Publicado: (2021)

Association of Titin-Truncating Genetic Variants With Life-threatening Cardiac Arrhythmias in Patients With Dilated Cardiomyopathy and Implanted Defibrillators
por: Corden, Ben, et al.
Publicado: (2019)

Left ventricular shape predicts arrhythmic risk in fibrotic dilated cardiomyopathy
por: Balaban, Gabriel, et al.
Publicado: (2021)

Outcomes of Spironolactone Withdrawal in Dilated Cardiomyopathy With Improved Ejection Fraction
por: Chen, Yanjia, et al.
Publicado: (2021)

Comprehensive Phenotypic Characterization of Late Gadolinium Enhancement Predicts Sudden Cardiac Death in Coronary Artery Disease
por: Jones, Richard E., et al.
Publicado: (2023)

Truncating Variants in Titin Independently Predict Early Arrhythmias in Patients With Dilated Cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2017)

Titin: a phenotype-genotype descriptive comparison of dilated cardiomyopathy
por: Baksi, Arun J, et al.
Publicado: (2014)

In-vivo cardiac DTI: An initial comparison of M012 compensated spin-echo and STEAM
por: Scott, Andrew D, et al.
Publicado: (2016)

An in-vivo comparison of stimulated-echo and motion compensated spin-echo sequences for 3 T diffusion tensor cardiovascular magnetic resonance at multiple cardiac phases
por: Scott, Andrew D., et al.
Publicado: (2018)

The promise and challenges of precision medicine in dilated cardiomyopathy
por: Mason, Samantha, et al.
Publicado: (2021)

Reevaluating the Genetic Contribution of Monogenic Dilated Cardiomyopathy
por: Mazzarotto, Francesco, et al.
Publicado: (2020)

Beta‐Blocker Use Is Associated With Prevention of Left Ventricular Remodeling in Recovered Dilated Cardiomyopathy
por: Enzan, Nobuyuki, et al.
Publicado: (2021)

Dilated cardiomyopathy
por: Schultheiss, Heinz-Peter, et al.
Publicado: (2019)

Iatrogenic myocarditis—biomarkers, cardiovascular MRI and the need for early diagnosis
por: Lota, Amrit S, et al.
Publicado: (2018)

A qualitative exploration of participant and investigator perspectives from the TRED‐HF trial
por: Papageorgiou, Vasiliki, et al.
Publicado: (2021)

Cardiovascular magnetic resonance T2 mapping detects myocardial edema in patients with chronic dilated cardiomyopathy
por: He, Taigang, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_odsdv9lforam1ns02jbu9gr7qb